GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkaloid AD Skopje (XMAE:ALK) » Definitions » Investments And Advances

Alkaloid AD Skopje (XMAE:ALK) Investments And Advances : MKD0 Mil (As of Mar. 2025)


View and export this data going back to . Start your Free Trial

What is Alkaloid AD Skopje Investments And Advances?

Alkaloid AD Skopje's Investments And Advances for the quarter that ended in Mar. 2025 was MKD0 Mil.


Alkaloid AD Skopje Investments And Advances Historical Data

The historical data trend for Alkaloid AD Skopje's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alkaloid AD Skopje Investments And Advances Chart

Alkaloid AD Skopje Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Alkaloid AD Skopje Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Alkaloid AD Skopje Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Alkaloid AD Skopje Business Description

Traded in Other Exchanges
N/A
Address
Boulevard Aleksandar, Makedonski 12, Skopje, MKD, 1000
Alkaloid AD Skopje is engaged in producing and selling pharmaceutical, chemical and cosmetic products, as well as goods from the herbal origin. Its segments are Pharmaceuticals, Chemicals, Cosmetics and Botanicals. It derives maximum revenue from Pharmaceuticals products segment.